ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,262.11
-0.29%
US Tech 100
18,022.40
-0.03%
Dow Jones
38,435.44
-0.65%
Brent Oil
78.275
-3.13%
Bitcoin
69,372.18
2.40%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/03/20242:34PMBusiness WireCollins joins Church Mutual® Marketing team
06/03/20242:34PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMAQWInternational Media Acquisition Corporation
06/03/20242:34PMPR Newswire (US)Albert Einstein College of Medicine Names Marla Keller, M.D., Executive Dean
06/03/20242:33PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
06/03/20242:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LEGLeggett and Platt Inc
06/03/20242:33PMBusiness WirePuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
06/03/20242:33PMBusiness WireNHC to Acquire White Oak Senior Living PortfolioAMEX:NHCNational HealthCare Corp
06/03/20242:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:SNDASonida Senior Living
06/03/20242:32PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
06/03/20242:32PMBusiness WirePSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis
06/03/20242:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GPIGroup 1 Automotive Inc
06/03/20242:31PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
06/03/20242:31PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
06/03/20242:31PMPR Newswire (US)James Scott Farrin Expands Personal Injury Team with Attorney Andréa Morelos
06/03/20242:31PMPR Newswire (US)Vintage Announces the Promotion of Shira Eting to Partner as well as the Appointment of Erez Mor as CISO
06/03/20242:30PMGlobeNewswire Inc.Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual MeetingTG:2GHMerus NV
06/03/20242:30PMGlobeNewswire Inc.MCLA-129 von Merus zeigt in Posterpräsentation auf der ASCO®-Jahrestagung 2024 eine vielversprechende Wirksamkeit als Einzelwirkstoff bei METex14-NSCLCTG:2GHMerus NV
06/03/20242:30PMGlobeNewswire Inc.L’anticorps MCLA-129 produit par Merus ou la promesse d’une monothérapie efficace dans le traitement du CPNPC présentant une mutation de l’exon 14 du gène MET - une présentation sous forme de poster est prévue lors du congrès annuel 2024 deTG:2GHMerus NV
06/03/20242:30PMBusiness WireMythic Therapeutics Presents Initial Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting
06/03/20242:30PMGlobeNewswire Inc.Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual MeetingNASDAQ:MRUSMerus NV
06/03/20242:30PMPR Newswire (US)Itaipu ends participation in the 10th World Water Forum
06/03/20242:30PMPR Newswire (US)Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib show clinically meaningful antitumor response and improved safety profile in patients with EGFR-mutated non-small cell lung cancer
06/03/20242:30PMPR Newswire (US)Itaipu ends participation in the 10th World Water Forum
06/03/20242:30PMPR Newswire (US)BRIXTON appoints Brian White, Industry Veteran, as SVP of US Wholesale
06/03/20242:30PMPR Newswire (Canada)Itaipu ends participation in the 10th World Water Forum
06/03/20242:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:WENWendys Company
06/03/20242:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LEGLeggett and Platt Inc
06/03/20242:29PMPR Newswire (US)Royce Small-Cap Trust, Inc. (formerly Royce Value Trust, Inc.) (NYSE-RVT) declares Second Quarter Common Stock Distribution of $0.28 Per ShareNYSE:RVTRoyce Small Cap Trust Inc
06/03/20242:29PMPR Newswire (Canada)Thalia Chooses Coveo to Deliver AI-Powered Search, Recommendations and Personalization to Book EnthusiastsTSX:CVOCoveo Solutions Inc
06/03/20242:28PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:VZVerizon Communications Inc

Your Recent History

NYSE
GME
GameStop
USOTC
TXTM
ProText Mobility (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
AXXA
Exxe (PK)
USOTC
AHRO
Authentic (CE)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
AGBA
AGBA
USOTC
VPLM
Voip Pal Com (QB)
USOTC
GRLT
Grillit (PK)
NYSE
AMC
AMC Entertainment
USOTC
ENZC
Enzolytics (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
MWWC
Marketing Worldwide (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
UBQU
Ubiquitech Software (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved